I. Diop‐Mar

850 total citations
28 papers, 623 citations indexed

About

I. Diop‐Mar is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, I. Diop‐Mar has authored 28 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 17 papers in Hepatology and 8 papers in Infectious Diseases. Recurrent topics in I. Diop‐Mar's work include Hepatitis B Virus Studies (25 papers), Hepatitis C virus research (9 papers) and Hepatitis Viruses Studies and Epidemiology (8 papers). I. Diop‐Mar is often cited by papers focused on Hepatitis B Virus Studies (25 papers), Hepatitis C virus research (9 papers) and Hepatitis Viruses Studies and Epidemiology (8 papers). I. Diop‐Mar collaborates with scholars based in France, Senegal and Burundi. I. Diop‐Mar's co-authors include Pierre Coursaget, B Yvonnet, J.P. Chiron, J. Chotard, M Sarr, R N'Doye, Pierre Le Cann, Didier Leboulleux, M Soumaré and E. H. Relyveld and has published in prestigious journals such as The Lancet, Journal of Hepatology and Infection and Immunity.

In The Last Decade

I. Diop‐Mar

28 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Diop‐Mar France 11 527 391 145 130 113 28 623
J. Chotard France 12 626 1.2× 495 1.3× 143 1.0× 140 1.1× 101 0.9× 18 738
Elena N. Lopareva United States 10 211 0.4× 197 0.5× 232 1.6× 56 0.4× 45 0.4× 15 422
D. West United States 6 367 0.7× 238 0.6× 87 0.6× 95 0.7× 128 1.1× 7 478
A. Delem Austria 14 472 0.9× 451 1.2× 246 1.7× 63 0.5× 68 0.6× 25 650
G. Zoulek Germany 9 301 0.6× 135 0.3× 90 0.6× 31 0.2× 85 0.8× 17 414
Jin-ye Yang China 13 502 1.0× 366 0.9× 218 1.5× 33 0.3× 25 0.2× 30 649
P. Mortimer United Kingdom 8 262 0.5× 100 0.3× 111 0.8× 27 0.2× 21 0.2× 10 349
L. Mazzotti Mexico 11 121 0.2× 41 0.1× 124 0.9× 93 0.7× 22 0.2× 33 307
Jennie Leydon Australia 12 259 0.5× 42 0.1× 99 0.7× 84 0.6× 57 0.5× 17 467
Leora Brown United States 6 382 0.7× 498 1.3× 305 2.1× 78 0.6× 23 0.2× 8 618

Countries citing papers authored by I. Diop‐Mar

Since Specialization
Citations

This map shows the geographic impact of I. Diop‐Mar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Diop‐Mar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Diop‐Mar more than expected).

Fields of papers citing papers by I. Diop‐Mar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Diop‐Mar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Diop‐Mar. The network helps show where I. Diop‐Mar may publish in the future.

Co-authorship network of co-authors of I. Diop‐Mar

This figure shows the co-authorship network connecting the top 25 collaborators of I. Diop‐Mar. A scholar is included among the top collaborators of I. Diop‐Mar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Diop‐Mar. I. Diop‐Mar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coursaget, Pierre, Bernard Fritzell, Christine Blondeau, Philippe Saliou, & I. Diop‐Mar. (1995). Simultaneous injection of plasma-derived or recombinant hepatitis B vaccines with yellow fever and killed polio vaccines. Vaccine. 13(1). 109–111. 11 indexed citations
2.
Coursaget, Pierre, Didier Leboulleux, M Soumaré, et al.. (1994). Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. Journal of Hepatology. 21(2). 250–254. 96 indexed citations
3.
Coursaget, Pierre, E. H. Relyveld, A. Brizard, et al.. (1992). Simultaneous injection of hepatitis B vaccine with BCG and killed poliovirus vaccine. Vaccine. 10(5). 319–321. 15 indexed citations
4.
Coursaget, Pierre, Bernard Fritzell, Christine Blondeau, et al.. (1992). Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine. Vaccine. 10(6). 379–382. 11 indexed citations
5.
Coursaget, Pierre, et al.. (1991). Simultaneous injection of hepatitis B and measles vaccines. Transactions of the Royal Society of Tropical Medicine and Hygiene. 85(6). 788–788. 7 indexed citations
6.
Coursaget, Pierre, Yves Buisson, B Yvonnet, et al.. (1990). Antibody response to preS1 in hepatitis-B-virus-induced liver disease and after immunization. Research in Virology. 141(5). 563–570. 10 indexed citations
7.
Coursaget, Pierre, R Kastally, B Yvonnet, et al.. (1990). Prevalence of hepatitis C virus infection in Africa: Anti-HCV antibodies in the general population and in patients suffering from cirrhosis or primary liver cancer. Research in Virology. 141(4). 449–454. 38 indexed citations
8.
Coursaget, Pierre, B Yvonnet, J. Chotard, et al.. (1990). Hepatitis B surface antigen reactivity in man due to a new variant of hepatitis B virus. Vaccine. 8. S15–S17. 9 indexed citations
9.
Samb, A, et al.. (1988). [Incidence of pathogenic Escherichia coli in acute infantile diarrhea in Dakar].. PubMed. 81(2). 202–10. 1 indexed citations
10.
Coursaget, Pierre, B Yvonnet, J. Chotard, et al.. (1987). Age‐ and sex‐related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). Journal of Medical Virology. 22(1). 1–5. 102 indexed citations
11.
Diallo, Souleymane, Mohammed A. Aziz, M. Larivière, et al.. (1986). A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 80(6). 927–934. 39 indexed citations
12.
Coursaget, Pierre, J. Chotard, I. Diop‐Mar, et al.. (1986). SEVEN-YEAR STUDY OF HEPATITIS B VACCINE EFFICACY IN INFANTS FROM AN ENDEMIC AREA (SENEGAL). The Lancet. 328(8516). 1143–1145. 125 indexed citations
13.
Coursaget, Pierre, B Yvonnet, J.P. Chiron, & I. Diop‐Mar. (1986). Long-term efficacy of hepatitis B vaccine in infants from an endemic area. Annales de l Institut Pasteur Virologie. 137. 221–224. 7 indexed citations
14.
Yvonnet, B, Pierre Coursaget, Vincent Deubel, et al.. (1986). Simultaneous administration of hepatitis B and yellow fever vaccines. Journal of Medical Virology. 19(4). 307–311. 23 indexed citations
16.
Coursaget, Pierre, et al.. (1985). [Hepatitis B and primary cancer of the liver in intertropical Africa].. PubMed. 33(4-5). 267–75. 1 indexed citations
17.
Yvonnet, B, Pierre Coursaget, F Denis, et al.. (1985). Immune response to hepatitis B vaccination at birth. Annales de l Institut Pasteur Virologie. 136(2). 151–160. 6 indexed citations
18.
Coursaget, Pierre, et al.. (1984). Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).. PubMed. 319–35. 7 indexed citations
19.
Coursaget, Pierre, Françis Barin, A Goudeau, et al.. (1983). Hepatitis B vaccine: immunization of children and newborns in an endemic area (Senegal).. PubMed. 54. 245–57. 10 indexed citations
20.
Coursaget, Pierre, J.P. Chiron, Françis Barin, et al.. (1982). Hepatitis B e antigen and alpha-ftoprotein in black african people suffering from liver cirrhosis. Annales de l Institut Pasteur Virologie. 133(4). 455–459. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026